CONSENSI FDA approval date

The FDA approved CONSENSI on 31 May 2018.

FDA approval date
31 May 2018

Drug identity has not yet been verified against registry records

Also recorded as AMLODIPINE BESYLATE; CELECOXIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-05-31DayCONSENSIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA210045", "applicant_as_listed_by_fda": "PURPLE BIOTECH", "brand_names": ["CONSENSI"], "active_ingredients": ["AMLODIPINE BESYLATE", "CELECOXIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180531", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026